BIOTRONIK’s latest insertable cardiac monitor, BIOMONITOR IV, comes with SmartECG, an intelligent system powered by artificial intelligence and advanced algorithms to provide actionable clinical insights. 1,2 Reduces 86% of false detections across all major arrhythmias 3 Streamlines ICM monitoring with intuitive templates and reports The industry’s first to discriminate between …

At BIOTRONIK, we are committed to helping people with heart and blood vessel diseases or chronic pain live fulfilling lives.

We are a leading global medical technology company with products and services that save and improve the lives of millions suffering from heart and blood vessel diseases, as well as chronic pain. Driven by a purpose to perfectly match technology with the human body, we are dedicated to innovation and quality to develop trusted cardiovascular, endovascular and …

301 Moved Permanently301 Moved Permanently nginx

What Is a Pacemaker? Pacemakers are small, battery-powered devices that are implanted near the collarbone and serve as the heart’s artificial “timekeeper”. A pacemaker system consists of a pulse generator as well as one or two special wires, called leads, that connect the heart with the pulse generator. When they sense a missed or irregular heartbeat, they can carry small …

BIOTRONIK will join at the European Heart Rhythm Association (EHRA) congress taking place in Vienna, Austria on March 30 – April 1, 2025. Join us for interactive sessions, lectures, hands-on experiences and networking with the BIOTRONIK professionals. Our highlights this year: Conduction System Pacing Atrial Fibrillation Management Workflow Optimization By …

BIOTRONIK is one of the world's leading medical technology companies in the field of Cardiac Rhythm Management and Vascular Intervention. We are represented in over 100 countries worldwide with products and services that are vital for people. This great responsibility is borne by our committed, highly specialized and exceptionally skilled employees, in research and …

+41 44 864 51 11+41 44 864 50 05BIOTRONIK AG

A real challenge exists in the clinical world today with the volume of data generated as more patients benefit from the proven value of long-term cardiac monitoring. Valuable time and resources are spent analyzing false positive arrhythmias, leaving patients waiting for accurate answers. The intelligent technology in BIOMONITOR IV can help. BIOMONITOR IV with …

Orsiro DES is indicated for discrete de novo stenotic lesions and in-stent restenotic lesions. a